Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $13.46 and traded as low as $9.82. Ono Pharmaceutical shares last traded at $10.70, with a volume of 513 shares changing hands.
Ono Pharmaceutical Stock Performance
The firm has a market cap of $5.50 billion, a P/E ratio of 7.99 and a beta of 0.56. The firm’s fifty day moving average price is $12.24 and its 200 day moving average price is $13.46.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Golden Cross Stocks: Pattern, Examples and Charts
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Ride Out The Recession With These Dividend Kings
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
